The direct cytotoxicity of complement activation has been demonstrated in patients with GAD-Ab-associated encephalitis, who exhibited increased transcriptional levels of complement protein genes (C3, C4A, C4B) and elevated levels of activated complement proteins in the CSF (9). The gene discussed is GAD1; the disease is viral encephalitis.